TY - JOUR
T1 - Microvascular reactivity in vitro blood perfused juxtamedullary nephrons from rats
AU - Casellas, D.
AU - Carmines, P. K.
AU - Navar, L. G.
N1 - Funding Information:
McLean, Jack Champion and Madeleine Dupont. These studies were performed during Dr. Casellas' tenure as Visiting Scientist at the University of Alabama in Birmingham. Dr. Carmines was a postdoc- toral fellow supported by training grants from the National Heart, Lung and Blood Institute (HL07457) and the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (AM07427). This work was supported by Grants HL26371 and HL18426 from the National Heart, Lung and Blood Institute. Portions of this study were presented at the 68th Annual Meeting of the Federation of American Societies for Experimental Biology, the IXth International Congress of Nephrology and the Third World Congress on Microcirculation.
PY - 1985
Y1 - 1985
N2 - The effects of angiotensin II (AII), epinephrine and changes in perfusion pressure on glomerular capillary and afferent arteriolar pressures were assessed using the in vitro blood perfused juxtamedullary nephron (JMN) preparation. At a perfusion pressure of 102 ± 1 mm Hg, glomerular capillary pressure (GCP) averaged 55 ± 1 mm Hg. Afferent arteriolar pressure (AAP), measured at early-to-mid afferent locations, was 88 ± 2 mm Hg and decreased to 71 ± 7 mm Hg at the most terminal segments, 50 to 80 μm from the glomerulus. In some nephrons, readjustments of GCP occurred in response to step changes in perfusion pressure within the range of 90 to 165 mm Hg. In 37 nephrons, bolus injections of AII into the blood caused dose-dependent and reversible decreases in GCP, ranging from -4 ± 1 mm Hg (12 to 25 pg) to -26 ± 4 mm Hg (20 ng). Similar decreases in GCP ranging from -9 ± 3 to -22 ± 3 mm Hg were observed in response to epinephrine (1.25 to 20 ng). Epinephrine also consistently reduced AAP by 37 ± 10% (N = 8). In contrast, AII typically increased pressure in the early and mid segments of the afferent arteriole, but caused variable responses in the late afferent arteriole. The responses to vasoconstrictor agents were not mimicked by increases in perfusion pressure per se. These results indicate that the preglomerular vasculature of in vitro JMN can exhibit autoregulatory behavior and is responsive to humoral vasoconstrictors. The response to epinephrine was generalized occurring along the entire preglomerular vasculature, while the predominant effects of AII were localized to terminal afferent structures, which may include intraglomerular constrictor elements.
AB - The effects of angiotensin II (AII), epinephrine and changes in perfusion pressure on glomerular capillary and afferent arteriolar pressures were assessed using the in vitro blood perfused juxtamedullary nephron (JMN) preparation. At a perfusion pressure of 102 ± 1 mm Hg, glomerular capillary pressure (GCP) averaged 55 ± 1 mm Hg. Afferent arteriolar pressure (AAP), measured at early-to-mid afferent locations, was 88 ± 2 mm Hg and decreased to 71 ± 7 mm Hg at the most terminal segments, 50 to 80 μm from the glomerulus. In some nephrons, readjustments of GCP occurred in response to step changes in perfusion pressure within the range of 90 to 165 mm Hg. In 37 nephrons, bolus injections of AII into the blood caused dose-dependent and reversible decreases in GCP, ranging from -4 ± 1 mm Hg (12 to 25 pg) to -26 ± 4 mm Hg (20 ng). Similar decreases in GCP ranging from -9 ± 3 to -22 ± 3 mm Hg were observed in response to epinephrine (1.25 to 20 ng). Epinephrine also consistently reduced AAP by 37 ± 10% (N = 8). In contrast, AII typically increased pressure in the early and mid segments of the afferent arteriole, but caused variable responses in the late afferent arteriole. The responses to vasoconstrictor agents were not mimicked by increases in perfusion pressure per se. These results indicate that the preglomerular vasculature of in vitro JMN can exhibit autoregulatory behavior and is responsive to humoral vasoconstrictors. The response to epinephrine was generalized occurring along the entire preglomerular vasculature, while the predominant effects of AII were localized to terminal afferent structures, which may include intraglomerular constrictor elements.
UR - http://www.scopus.com/inward/record.url?scp=0022393044&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022393044&partnerID=8YFLogxK
U2 - 10.1038/ki.1985.194
DO - 10.1038/ki.1985.194
M3 - Article
C2 - 4087691
AN - SCOPUS:0022393044
SN - 0085-2538
VL - 28
SP - 752
EP - 759
JO - Kidney International
JF - Kidney International
IS - 5
ER -